Literature DB >> 8839684

Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response.

M Jerling1.   

Abstract

The population approach is a general term covering different aspects of kinetic and dynamic data collected mainly from drug-treated patients and new techniques allowing evaluation of sparse observations from each subject. Such data originate from clinically relevant conditions and can give information on several qualities of a drug. An example is given with the tricyclic antidepressant nortriptyline for which the kinetics and the concentration-effect relationship have been thoroughly documented previously with conventional techniques. We have evaluated retrospective data from a therapeutic drug monitoring service using a nonparametric population kinetic method (NPML) that allows description of kinetic outliers and nonlinear relationships between kinetic parameters and covariates. In addition, drug interactions, nonlinear kinetics and dosing habits were studied with other techniques corroborating previous results and adding new information. The concentration-effect relationship could not be evaluated from our data as information on efficacy and adverse effects was of too low quality. However, several controlled studies have defined a therapeutic concentration interval and a discussion on dosing strategies is based on this interval. Collection of sparse data in patients during phases II-IV of drug development as a complement to conventional studies is highly recommendable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839684     DOI: 10.1007/BF03190259

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  46 in total

1.  Plasma-nortriptyline levels in endogenous depression.

Authors:  P Kragh-Sørensen; M Asberg; C Eggert-Hansen
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

2.  Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach.

Authors:  N Taright; F Mentré; A Mallet; R Jouvent
Journal:  Ther Drug Monit       Date:  1994-06       Impact factor: 3.681

3.  Monitoring plasma concentration of nortriptyline. Methodological, pharmakokinetic and clinical aspects.

Authors:  P Kragh-Sørensen
Journal:  Dan Med Bull       Date:  1985-03

4.  Dose-dependent kinetics of imipramine in elderly patients.

Authors:  M Bjerre; L F Gram; P Kragh-Sørensen; C B Kristensen; O L Pedersen; M Møller; P Thayssen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers.

Authors:  S Dawling; P Crome; R Braithwaite
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

6.  Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man.

Authors:  L Bertilsson; M Eichelbaum; B Mellström; J Säwe; H U Schulz; F Sjöqvist
Journal:  Life Sci       Date:  1980-11-03       Impact factor: 5.037

7.  Pharmacokinetics and the effects of nortriptyline in geriatric depressed patients.

Authors:  R C Smith; K Reed; D E Leelavathi
Journal:  Psychopharmacol Bull       Date:  1980-07

8.  Dosing of antidepressants--the unknown art.

Authors:  M Jerling
Journal:  J Clin Psychopharmacol       Date:  1995-12       Impact factor: 3.153

9.  Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.

Authors:  P Kragh-Sorensen; C E Hansen; P C Baastrup; E F Hvidberg
Journal:  Psychopharmacologia       Date:  1976-02-02

10.  Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man.

Authors:  L F Gram; K F Overo
Journal:  Br Med J       Date:  1972-02-19
View more
  1 in total

Review 1.  Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions.

Authors:  M Gex-Fabry; A E Balant-Gorgia; L P Balant
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.